Larry Ramer

Larry Ramer

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

7 Stocks That Could Skyrocket in the Next 12 Months

With the macro environment becoming excellent and much of the Street starting to turn bullish, it's time to find superb stocks to buy. 

Bed Bath & Beyond Stock Alert: Sell Your BBBY Immediately!

With Bed Bath & Beyond likely heading to bankruptcy sooner rather than later, investors should unload BBBY stock.

Dear META Stock Fans, Mark Your Calendars for TODAY

META stock is in the news this morning because the company is reportedly undertaking its latest round of layoffs. 

NVDA Stock Alert: Is Nvidia Really Worth $355?

NVDA stock is advancing in early trading. HSBC predicts that Nvidia will be boosted by high prices for its chips that enable AI systems.

Moderna (MRNA) Stock Sinks Despite Positive Cancer Vaccine Update

MRNA stock is sinking this morning despite Moderna releasing positive Phase 2b data on its mRNA cancer vaccine yesterday.